Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for EMA
[Guest post] Covid-19 Treatments: The Issue of Orphan Drug Status and Patents [Guest post] Covid-19 Treatments: The Issue of Orphan Drug Status and Patents Reviewed by Frantzeska Papadopoulou on Friday, April 03, 2020 Rating: 5
The right of the public to access documents v the right to confidentiality for marketing authorization (MA) documents: Transparency wins out in yesterday’s CJEU rulings The right of the public to access documents v the right to confidentiality for marketing authorization (MA) documents: Transparency wins out in yesterday’s CJEU rulings Reviewed by Frantzeska Papadopoulou on Thursday, January 23, 2020 Rating: 5
EMA relocation: and the winner is... EMA relocation: and the winner is... Reviewed by Eibhlin Vardy on Monday, November 20, 2017 Rating: 5
EMA/Commission guidance re centralised procedure and Brexit EMA/Commission guidance re centralised procedure and Brexit Reviewed by Eibhlin Vardy on Monday, June 05, 2017 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.